Assessment of the Effects on the Skin Microbiome of Amending an Over-the-counter Eczema Product With Activated Oil (AO)

Inclusion Criteria

• •Provision of signed and dated informed consent form.
• •Stated willingness to comply with all study procedures and availability for the duration of the study.
• •Male or female subjects aged who have a recent eczema itch flareup and/or pre-flare-up symptoms at screening as determined by visual analog scale (VAS).
• •Diagnosis of mild to moderate eczema (grade 3 - 7 on the Rajka-Langeland severity index).
• •Having a target lesion with an ADSI score of 6-12 and an erythema and pruritus subscore of ³2 (moderate).
• •Generally good health based on reported history.
• •Able to discontinue all medical and over the counter topical emollients, moisturizers, and / or other skin barrier lotions.
• •Females of child-bearing potential should agree to continue using a medically acceptable method of birth control throughout the study and for 30 days immediately after the last dose of study drug.
• •Ability to administer topical medication and be willing to adhere to the study interventions.
• •Agreement to adhere to Lifestyle Considerations throughout the duration of the study.